Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-11-19

FDA Approved: ADVIL COLD AND SINUS — Supplemental Application (Haleon US Holdings LLC)

View source ↗

Summary

FDA approved a supplemental application for Advil Cold and Sinus, a combination of ibuprofen and pseudoephedrine hydrochloride, from Haleon US Holdings LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ADVIL COLD AND SINUS (Ibuprofen and pseudoephedrine hydrochloride)

Snippet

SUPPL AP for ADVIL COLD AND SINUS (IBUPROFEN AND PSEUDOEPHEDRINE HYDROCHLORIDE)